[go: up one dir, main page]

NO913833D0 - 4- eller 5-substituerte pyridin-2-karbonsyrer, fremgangsmaate til deres fremstilling samt anvendelse derav som legemiddel. - Google Patents

4- eller 5-substituerte pyridin-2-karbonsyrer, fremgangsmaate til deres fremstilling samt anvendelse derav som legemiddel.

Info

Publication number
NO913833D0
NO913833D0 NO913833A NO913833A NO913833D0 NO 913833 D0 NO913833 D0 NO 913833D0 NO 913833 A NO913833 A NO 913833A NO 913833 A NO913833 A NO 913833A NO 913833 D0 NO913833 D0 NO 913833D0
Authority
NO
Norway
Prior art keywords
medicine
procedure
preparation
substituted pyridin
carbon acids
Prior art date
Application number
NO913833A
Other languages
English (en)
Other versions
NO913833L (no
Inventor
Ekkehard Baader
Martin Bickel
Volkmar Guenzler-Pukall
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO913833D0 publication Critical patent/NO913833D0/no
Publication of NO913833L publication Critical patent/NO913833L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO91913833A 1990-10-01 1991-09-30 4- eller 5-substituerte pyridin-2-karboksylsyrer og fremgangsmaate for fremstilling derav NO913833L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4030999A DE4030999A1 (de) 1990-10-01 1990-10-01 4- oder 5-substituierte pyridin-2-carbonsaeuren, verfahren zu deren herstellung sowie deren verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
NO913833D0 true NO913833D0 (no) 1991-09-30
NO913833L NO913833L (no) 1992-04-02

Family

ID=6415344

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91913833A NO913833L (no) 1990-10-01 1991-09-30 4- eller 5-substituerte pyridin-2-karboksylsyrer og fremgangsmaate for fremstilling derav

Country Status (19)

Country Link
EP (1) EP0479178A3 (no)
JP (1) JPH072777A (no)
KR (1) KR920008000A (no)
CN (1) CN1060464A (no)
AU (1) AU8485191A (no)
BR (1) BR9104204A (no)
CA (1) CA2052509A1 (no)
CS (1) CS299091A3 (no)
DE (1) DE4030999A1 (no)
FI (1) FI914557A (no)
HU (1) HUT59101A (no)
IE (1) IE913436A1 (no)
IL (1) IL99606A0 (no)
MA (1) MA22312A1 (no)
MX (1) MX9101348A (no)
NO (1) NO913833L (no)
PL (1) PL291880A1 (no)
PT (1) PT99133A (no)
ZA (1) ZA917806B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW199147B (no) * 1991-03-18 1993-02-01 Hoechst Ag
WO2017161555A1 (zh) * 2016-03-25 2017-09-28 沈阳三生制药有限责任公司 用于合成被芳基或杂芳基取代的5-羟基-1,7-萘啶化合物的中间体及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3432094A1 (de) * 1984-08-31 1986-03-06 Hoechst Ag, 6230 Frankfurt Ester der pyridin-2,4- und -2,5- dicarbonsaeure als arzneimittel zur inhibierung der prolin- und lysinhydroxylase
DE3703963A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,,5-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben, sowie arzneimittel auf basis dieser verbindungen
DE3707429A1 (de) * 1987-03-07 1988-09-15 Hoechst Ag Substituierte pyridin-2,4-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen
DE3924093A1 (de) * 1989-07-20 1991-02-07 Hoechst Ag N,n'-bis(alkoxy-alkyl)-pyridin-2,4-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung

Also Published As

Publication number Publication date
AU8485191A (en) 1992-04-02
EP0479178A3 (en) 1992-10-28
IL99606A0 (en) 1992-08-18
FI914557A0 (fi) 1991-09-27
CA2052509A1 (en) 1992-04-02
HU913120D0 (en) 1992-01-28
FI914557A (fi) 1992-04-02
JPH072777A (ja) 1995-01-06
MA22312A1 (fr) 1992-07-01
PT99133A (pt) 1992-08-31
KR920008000A (ko) 1992-05-27
HUT59101A (en) 1992-04-28
BR9104204A (pt) 1992-06-02
DE4030999A1 (de) 1992-04-09
NO913833L (no) 1992-04-02
PL291880A1 (en) 1992-06-26
MX9101348A (es) 1992-06-05
ZA917806B (en) 1992-05-27
IE913436A1 (en) 1992-04-08
CS299091A3 (en) 1992-04-15
EP0479178A2 (de) 1992-04-08
CN1060464A (zh) 1992-04-22

Similar Documents

Publication Publication Date Title
NO881164D0 (no) Substituerte 9-amino-tetrahydroakridiner og relaterte forbindelser, en fremgangsmaate for deres fremstilling og deres bruk som medikamenter.
NO895067D0 (no) Fremgangsmaate til fremstilling av derivater av alfa, d-glukofuranose.
NO871052L (no) 1,1-disubstituerte cyklopropanderivater, fremgangsmaate til deres fremstilling og deres anvendelse.
NO880473L (no) Fremgangsmaate til fremstilling av substituerte 3,4-dihydro-2h-benzopyraner og deres anvendelse som legemiddel.
NO913834D0 (no) 4- eller 5-substituerte pyridin-2-karbonsyrer, fremgangsmaate til deres fremstilling samt anvendelse derav som legemiddel.
NO875051L (no) Derivater og bicykliske aminokarboksylsyrer, fremgangsmaate og mellomprodukter til deres fremstilling, samt deres anvendelse.
DK135988A (da) 2,5-dihydropyrroler, fremgangsmaader til deres fremstilling samt deres anvendelse som herbicider
NO863944D0 (no) L-dopa-derivater, fremgangsmaate til deres fremstilling og farmasoeytisk blanding inneholdende disse derivater.
NO880474L (no) Alkylsubstituerte n-benzopyranyllaktaner, fremgangsmaate til deres fremstilling, deres anvendelse samt farmasoeytiskepreparater paa basis av disse forbindelser.
NO862976D0 (no) Oksalkylerte polyesteraminer, fremgangsmaate til deres fremstilling og deres anvendelse.
DK303688D0 (da) Polyoxygenerede labdanderivater, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
DK631588A (da) Transformerede maelkesyrebakterier, deres fremstilling, isolering og anvendelse samt fremgangsmaade til isolering af funktionelle gensegmenter.
DK422488A (da) Arylpyrroler, fremgangsmaader til deres fremstilling samt deres anvendelse som insecticider, acaricider og nematodicider
NO874888L (no) Fremgangsmaate til fremstilling av aminometyl-5,6,7,8-tetrahydronaftyloksyeddiksyrer.
NO863460D0 (no) Fremgangsmaate til fremstilling av 6-fenoksymetyl-4-hydroksy-tetrahydropyran-2-on, fremgangsmaate til deres fremstilling, og deres anvendelse som legemiddel, farmasoeytiske preparater og mellomprodukter.
DK393788A (da) Substituerede thienoimidazolderivater, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
NO913833D0 (no) 4- eller 5-substituerte pyridin-2-karbonsyrer, fremgangsmaate til deres fremstilling samt anvendelse derav som legemiddel.
NO863461L (no) 3-desmetyl-mevalonsyrederivater, fremgangsmaate til deres fremstilling, farmasoeytiske preparater paa basis av disse forbindelser, deres anvendelse, samt mellomprodukter.
NO865139D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperazin-1,4-naftalendion-derivater.
NO882065D0 (no) Diarylalkyl-substituerte alkylaminer, fremgangsmaate til deres fremstilling, deres anvendelse, samt legemidler som inneholder denne.
NO881775D0 (no) Kondenserte heteroalkylen-kinolinaminer, en fremgangsmaate og mellomprodukter for deres fremstilling samt anvendelse av forbindelsene som medikamenter.
DK260884A (da) 7-oxo-4-thia-1-azabicyclo(3.2.0)hept-2-en-derivater, fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
NO882028L (no) Fremgangsmaate for fremstilling av cardiotone, tricykliskeimidazoloner.
DK348388D0 (da) Sulfonylurinstofforbindelser, fremgangsmaade til deres fremstilling, samt deres anvendelser som ukrudtsbekaempelsesmidler
DK120889A (da) 3-(2,3,4,5,6-pentafluorphenoxy)-8-azabicyclooe3.2.1aaoctaner, en fremgangsmaade til deres fremstilling og deres anvendelse som medikamenter